Sodium-dependent phosphate transporter 2 (PiT-2) (PiT2)

Sodium-dependent phosphate transporter 2 (PiT2), encoded by the SLC20A2 gene, is a multi-pass membrane protein that functions as a type III sodium-phosphate symporter [1, 3]. It is essential for maintaining inorganic phosphate homeostasis across various tissues, with particularly high activity in the brain's basal ganglia and vascular smooth muscle cells [1, 4]. The protein facilitates the uptake of inorganic phosphate from the extracellular environment, which is critical for cellular metabolism, signal transduction, and the synthesis of nucleic acids and lipids [1, 3]. Mutations in the SLC20A2 gene are the primary cause of Primary Familial Brain Calcification (PFBC), also known as Fahr's disease, where impaired phosphate transport leads to pathological calcium deposits in the brain [1, 2, 4]. Beyond its transport function, PiT2 serves as a cell surface receptor for amphotropic murine leukemia viruses, facilitating viral entry into host cells [6, 9]. While there are currently no approved drugs that specifically target PiT2, it is considered a significant potential target for treating neurodegenerative and vascular calcification disorders [22, 24]. Experimental research has explored the use of small molecules like Compound C and Wortmannin to study its regulation via phosphorylation and membrane trafficking [22]. Therapeutic strategies under investigation aim to enhance the activity or membrane expression of the transporter to counteract the effects of haploinsufficiency in PFBC patients [22]. Monitoring phosphate levels in the cerebrospinal fluid and PiT2 levels in urinary extracellular vesicles are emerging as potential biomarkers for assessing transporter function and disease progression [4, 27, 29]. Overall, PiT2 represents a critical node in mineral homeostasis with broad implications for neurology and cardiovascular health [5, 8, 25].

Other names

SLC20A2Solute carrier family 20 member 2GLVR-2GLVR2IBGC1IBGC3MLVARPIT-2RAM1Ram-1IBGC2

Inhibition of AMPK- or AKT-mediated phosphorylation to reduce membrane localization [22]; competitive inhibition of phosphate transport [21]; viral receptor binding and entry [6, 9].